NLRP3 inflammasome as a treatment target in atherosclerosis: A focus on statin therapy

dc.creatorParsamanesh N.
dc.creatorMoossavi M.
dc.creatorBahrami A.
dc.creatorFereidouni M.
dc.creatorBarreto G.
dc.creatorSahebkar A.
dc.date.accessioned2020-09-02T22:25:23Z
dc.date.accessioned2022-11-08T20:21:32Z
dc.date.available2020-09-02T22:25:23Z
dc.date.available2022-11-08T20:21:32Z
dc.date.created2020-09-02T22:25:23Z
dc.date.issued2019
dc.identifier73, , 146-155
dc.identifier15675769
dc.identifierhttps://hdl.handle.net/20.500.12728/5760
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5144056
dc.languageen
dc.publisherElsevier B.V.
dc.subjectAcute coronary syndrome
dc.subjectCoronary atherosclerosis
dc.subjectInflammation
dc.subjectNLRP3
dc.subjectNOD-like receptor
dc.subjectantiinflammatory agent
dc.subjectcryopyrin
dc.subjecthydroxymethylglutaryl coenzyme A reductase inhibitor
dc.subjectinflammasome
dc.subjectcryopyrin
dc.subjecthydroxymethylglutaryl coenzyme A reductase inhibitor
dc.subjectatherosclerosis
dc.subjectcardiovascular disease
dc.subjectdisease association
dc.subjectdrug efficacy
dc.subjectdrug targeting
dc.subjecthuman
dc.subjectnonhuman
dc.subjectpriority journal
dc.subjectprotein assembly
dc.subjectprotein family
dc.subjectprotein function
dc.subjectrandomized controlled trial (topic)
dc.subjectReview
dc.subjectsignal transduction
dc.subjectanimal
dc.subjectatherosclerosis
dc.subjectimmunology
dc.subjectAnimals
dc.subjectAtherosclerosis
dc.subjectHumans
dc.subjectHydroxymethylglutaryl-CoA Reductase Inhibitors
dc.subjectNLR Family, Pyrin Domain-Containing 3 Protein
dc.titleNLRP3 inflammasome as a treatment target in atherosclerosis: A focus on statin therapy
dc.typeReview


Este ítem pertenece a la siguiente institución